RU2004119585A -
METHOD FOR TREATING CHRONIC CYSTITIS IN CHILDREN
- Google Patents
METHOD FOR TREATING CHRONIC CYSTITIS IN CHILDREN
Download PDF
Info
Publication number
RU2004119585A
RU2004119585ARU2004119585/14ARU2004119585ARU2004119585ARU 2004119585 ARU2004119585 ARU 2004119585ARU 2004119585/14 ARU2004119585/14 ARU 2004119585/14ARU 2004119585 ARU2004119585 ARU 2004119585ARU 2004119585 ARU2004119585 ARU 2004119585A
Российский государственный медицинский университет (RU)
Российский государственный медицинский университет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Российский государственный медицинский университет (RU), Российский государственный медицинский университетfiledCriticalРоссийский государственный медицинский университет (RU)
Priority to RU2004119585/14ApriorityCriticalpatent/RU2270678C1/en
Publication of RU2004119585ApublicationCriticalpatent/RU2004119585A/en
Application grantedgrantedCritical
Publication of RU2270678C1publicationCriticalpatent/RU2270678C1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Claims (1)
Способ лечения хронического цистита у детей от 5 до 16 лет на основе инсталляций мочевого пузыря антибиотиком диоксидином, отличающийся тем, что раствор диоксидина используют в концентрации 0,5% с одновременной инсталляцией препарата "Энтеросгель" в соотношении по объему 1:1.A method for the treatment of chronic cystitis in children from 5 to 16 years old based on bladder installations with dioxidine antibiotic, characterized in that the solution of dioxin is used in a concentration of 0.5% with the simultaneous installation of Enterosgel in a ratio of 1: 1 in volume.
RU2004119585/14A2004-06-302004-06-30Method for treating children for chronic cystitis
RU2270678C1
(en)
COMPOSITION, KIT, AND METHODS TO REDUCE A SIDE TREATMENT EFFECT WITH A CALCINEURIN INHIBITOR, TO INCREASE A THERAPEUTIC EFFECT OF A CALCINEURIN INHIBITOR AND TO CHANGE THE CONCENTRATION OF TACROLIMUS OR ANALYLOGAL ANALOGUE